Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays
- 12 March 2007
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 43 (4) , 1256-1261
- https://doi.org/10.1016/j.jpba.2006.10.023
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MSNeurology, 2006
- Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicityClinical Immunology, 2005
- How similar do 'biosimilars' need to be?Nature Biotechnology, 2004
- Anti-interferon antibodies in multiple sclerosis. Molecular basis and their impact on clinical efficacyFrontiers in Bioscience-Landmark, 2004
- Long-term stabilization of recombinant human interferon α 2b in aqueous solution without serum albuminInternational Journal of Pharmaceutics, 2003
- Neutralizing antibodies during treatment of secondary progressive MS with interferon β-1bNeurology, 2003
- Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]Neurology, 2002
- PRISMS-4: Long-term efficacy of interferon-β-1a in relapsing MSNeurology, 2001
- Randomized controlled trial of interferon- beta-1a in secondary progressive MSNeurology, 2001
- The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon β-1bNeurology, 1999